
CSL Investor Relations Material
Latest events

H1 2025
CSL
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from CSL Limited
Access all reports
CSL Limited is a global biotechnology company specializing in the development and manufacture of products that treat serious human medical conditions. It operates across segments such as biotherapies, vaccines, and plasma protein therapies, serving the healthcare sector. CSL provides critical biological medicines to healthcare providers worldwide through its research, development, and manufacturing operations. The company is headquartered in Melbourne, Australia, and its shares are listed on the ASX.
Key slides for CSL Limited


Shareholder Briefing
CSL Limited


Shareholder Briefing
CSL Limited
Latest articles
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
)
500 Years of Craft, One Family Legacy: Beretta Holding's Global Expansion
How Beretta Holding managed to transform from a 16th-century gun barrel producer into a global industrial group while preserving 500 years of legacy.
27 Jun 2025
)
Shuntaro Furukawa: The Sixth President of Nintendo
Shuntaro Furukawa, Nintendo's sixth president, went from a childhood fan to leading the company through global expansion and the launch of Switch 2.
23 Jun 2025
Ticker symbol
CSL
Country
🇦🇺 Australia